X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12252) 12252
Magazine Article (7) 7
Publication (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Newsletter (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10026) 10026
antineoplastic agents, phytogenic - administration & dosage (6961) 6961
female (5797) 5797
animals (4756) 4756
male (4680) 4680
oncology (4231) 4231
antineoplastic agents, phytogenic - pharmacology (4131) 4131
antineoplastic agents, phytogenic - therapeutic use (3851) 3851
pharmacology & pharmacy (3188) 3188
middle aged (3140) 3140
cancer (2964) 2964
paclitaxel - administration & dosage (2929) 2929
mice (2925) 2925
aged (2706) 2706
chemotherapy (2507) 2507
cell line, tumor (2455) 2455
adult (2416) 2416
paclitaxel (2302) 2302
antineoplastic agents, phytogenic - adverse effects (2201) 2201
antineoplastic combined chemotherapy protocols - therapeutic use (2014) 2014
apoptosis (1819) 1819
treatment outcome (1714) 1714
antineoplastic agents, phytogenic - pharmacokinetics (1688) 1688
dose-response relationship, drug (1556) 1556
camptothecin - analogs & derivatives (1545) 1545
antineoplastic agents, phytogenic - chemistry (1496) 1496
apoptosis - drug effects (1473) 1473
drug administration schedule (1444) 1444
paclitaxel - therapeutic use (1326) 1326
breast neoplasms - drug therapy (1309) 1309
lung neoplasms - drug therapy (1146) 1146
cell proliferation - drug effects (1129) 1129
camptothecin - administration & dosage (1128) 1128
rats (1079) 1079
neoplasms - drug therapy (1021) 1021
paclitaxel - adverse effects (1001) 1001
care and treatment (968) 968
cell survival - drug effects (966) 966
in-vitro (943) 943
analysis (935) 935
mice, nude (911) 911
research (906) 906
taxol (901) 901
paclitaxel - pharmacology (900) 900
plant extracts - pharmacology (900) 900
chemistry, medicinal (893) 893
tumors (880) 880
nanoparticles (867) 867
therapy (863) 863
pharmacokinetics (850) 850
drug delivery systems (843) 843
breast cancer (790) 790
xenograft model antitumor assays (777) 777
mice, inbred balb c (774) 774
antineoplastic agents (767) 767
cisplatin (765) 765
expression (748) 748
breast neoplasms - pathology (738) 738
infusions, intravenous (738) 738
docetaxel (737) 737
antineoplastic agents - administration & dosage (728) 728
time factors (713) 713
cisplatin - administration & dosage (709) 709
phytotherapy (705) 705
antineoplastic combined chemotherapy protocols - adverse effects (702) 702
etoposide - administration & dosage (697) 697
paclitaxel - pharmacokinetics (695) 695
antimitotic agents (687) 687
cytotoxicity (681) 681
cells (674) 674
chemistry, multidisciplinary (671) 671
carcinoma (670) 670
administration, oral (658) 658
carcinoma, non-small-cell lung - drug therapy (657) 657
medicine & public health (654) 654
irinotecan (648) 648
aged, 80 and over (626) 626
health aspects (622) 622
paclitaxel - analogs & derivatives (613) 613
combined modality therapy (604) 604
metastasis (604) 604
survival analysis (592) 592
drugs (588) 588
inhibition (584) 584
taxoids (582) 582
plant extracts - therapeutic use (575) 575
biochemistry & molecular biology (574) 574
antineoplastic combined chemotherapy protocols - administration & dosage (573) 573
ovarian neoplasms - drug therapy (573) 573
growth (561) 561
antimetabolites, antineoplastic - administration & dosage (541) 541
trial (533) 533
doxorubicin (529) 529
pharmacology/toxicology (528) 528
vinblastine - analogs & derivatives (526) 526
toxicity (523) 523
antineoplastic agents, phytogenic - toxicity (520) 520
camptothecin - therapeutic use (520) 520
drug therapy (518) 518
drug resistance, neoplasm (513) 513
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11473) 11473
Japanese (655) 655
Chinese (268) 268
French (130) 130
German (123) 123
Italian (40) 40
Russian (39) 39
Spanish (21) 21
Hungarian (15) 15
Portuguese (9) 9
Dutch (5) 5
Hebrew (4) 4
Lithuanian (4) 4
Danish (3) 3
Polish (3) 3
Ukrainian (3) 3
Czech (2) 2
Croatian (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules. In this study, we investigated the... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | APOPTOSIS | ANTIINFLAMMATORY ACTIVITY | CELL-CYCLE ARREST | PROLIFERATION | FLUOROURACIL | CANCER | IN-VITRO | ONCOLOGY | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | EA.hy 926 endothelial cells | INHIBITORS | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
Journal Article
Journal Article
Nanomedicine, ISSN 1549-9634, 2016, Volume 12, Issue 3, pp. 655 - 664
Journal Article
European journal of nutrition, ISSN 1436-6215, 2017, Volume 57, Issue 3, pp. 929 - 938
Journal Article
Journal of controlled release, ISSN 0168-3659, 2017, Volume 263, pp. 79 - 89
The abnormal tumor microenvironment (TME) featured with hypoxia, acidosis, dense extracellular matrix and increased tumor interstitial fluid pressure is... 
Albumin | Deep penetration | Hypoxia relieve | Self-assembly | Combination therapy | PHOTODYNAMIC THERAPY | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | OXYGEN | NANOPARTICLES | GUIDED PHOTOTHERMAL THERAPY | MICROENVIRONMENT | PHARMACOLOGY & PHARMACY | HYDROGEN-PEROXIDE | ENZYME ENCAPSULATION | RADIOTHERAPY | Neoplasms - metabolism | Porphyrins - administration & dosage | Catalase - therapeutic use | Theranostic Nanomedicine | Nanoparticles - chemistry | Porphyrins - chemistry | Serum Albumin - administration & dosage | Tumor Microenvironment | Hydrogen Peroxide - chemistry | Radiation-Sensitizing Agents - therapeutic use | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Neoplasms - therapy | Radiation-Sensitizing Agents - administration & dosage | Nanoparticles - therapeutic use | Female | Radiation-Sensitizing Agents - chemistry | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Serum Albumin - chemistry | Porphyrins - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Combined Modality Therapy | Paclitaxel - therapeutic use | Serum Albumin - therapeutic use | Catalase - administration & dosage | Animals | Mice, Nude | Cell Line, Tumor | Hypoxia | Nanoparticles - administration & dosage | Neoplasms - pathology | Catalase - chemistry | Chemotherapy | Pharmaceutical industry | Cancer | Enzymes
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 3/2008, Volume 108, Issue 2, pp. 241 - 250
Journal Article
Journal of controlled release, ISSN 0168-3659, 2016, Volume 240, pp. 191 - 201
...-soluble chemotherapeutic agent. In this review article, preclinical and clinical research on PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol... 
Drug combination | Prodrugs | Hydrogels | Block copolymer | Controlled release | Drug solubilization | Polymeric micelles | DIBLOCK COPOLYMERS | CREMOPHOR-FREE | ANTICANCER DRUG | BLOCK-COPOLYMER MICELLES | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | BREAST-CANCER | PARENTERAL DELIVERY | IN-VIVO | ACID) MICELLES | PHARMACOLOGY & PHARMACY | Neoplasms - metabolism | Paclitaxel - metabolism | Humans | Polyethylene Glycols - chemistry | Antineoplastic Agents - administration & dosage | Phase Transition | Antineoplastic Agents - metabolism | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Lactates - administration & dosage | Micelles | Polyesters - administration & dosage | Antineoplastic Agents, Phytogenic - metabolism | Paclitaxel - administration & dosage | Lactates - chemistry | Polyethylene Glycols - metabolism | Gels | Solubility | Antineoplastic Agents, Phytogenic - chemistry | Antineoplastic Agents - chemistry | Polyethylene Glycols - administration & dosage | Neoplasms - drug therapy | Polyesters - chemistry | Animals | Lactates - metabolism | Polyesters - metabolism | Drug Delivery Systems - trends | Drug Delivery Systems - methods | Drugs | Chemotherapy | Drug delivery systems | Polyethylene glycol | Polyols | Organic acids | Vehicles | Cancer | Medical research | Drugstores | Antineoplastic agents | Antimitotic agents | Pharmacy | Medicine, Experimental | Research institutes | Lactic acid | Drug therapy, Combination | controlled release | drug solubilization | polymeric micelles | drug combination | hydrogels | prodrugs
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2004, Volume 22, Issue 9, pp. 1589 - 1597
Journal Article
Journal Article